Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Damien M. Miran, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Damien Miran's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Damien Miran has written about over time.
Affect, 1 publications between 2022 and 2022, average publication date December 2022. Anxiety, 1 publications between 2022 and 2022, average publication date December 2022. Brain Neoplasms, 1 publications between 2022 and 2022, average publication date December 2022. Health Personnel, 1 publications between 2022 and 2022, average publication date December 2022. Proxy, 1 publications between 2022 and 2022, average publication date December 2022. Caregivers, 1 publications between 2022 and 2022, average publication date December 2022. Home Care Services, 1 publications between 2022 and 2022, average publication date December 2022. Outpatients, 1 publications between 2022 and 2022, average publication date December 2022. Humans, 3 publications between 2022 and 2024, average publication date July 2023. Hematopoietic Stem Cell Transplantation, 2 publications between 2022 and 2024, average publication date October 2023. Graft vs Host Disease, 1 publications between 2024 and 2024, average publication date August 2024. Survivors, 1 publications between 2024 and 2024, average publication date August 2024. Transplantation, Homologous, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Miran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.